Prevention and Restraining of Induced-demand for Community Health Services by Contracted Family Doctors in China
1.Affiliated Hospital of Hebei University of Engineering,Handan 056002,China
2.Hua Wei Tong Medical Research Center,Beijing 100053,China
3.Chinese?General?Practice?Press,Beijing 100053,China
*Corresponding author:HAN Jianjun,Professor;E-mail:chinagp@vip.sina.com
YIN Tianlu,GAO Xiaohuan,HAN Jianjun. Prevention and Restraining of Induced-demand for Community Health Services by Contracted Family Doctors in China [J]. Chinese General Practice, 2020, 23(34): 4315-4319. DOI: 10.12114/j.issn.1007-9572.2020.00.598.
尹天露,高晓欢,韩建军. 我国家庭医生签约服务背景下社区卫生服务机构诱导需求的防范和规制研究[J]. 中国全科医学, 2020, 23(34): 4315-4319. DOI: 10.12114/j.issn.1007-9572.2020.00.598.
[1]袁目北,陈在余.医生诱导需求对我国医疗费用增长的影响[J].中国药物经济学,2020,15(5):30-37,53.DOI:10.12010/j.issn.1673-5846.2020.05.005.
YUAN M B,CHEN Z Y.The influence of doctor-induced demand on the growth of medical expenses in China[J].China Journal of Pharmaceutical Economics,2020,15(5):30-37,53.DOI:10.12010/j.issn.1673-5846.2020.05.005.
[2]国务院医改办,原国家卫生计生委,原国家发展改革委,等.关于印发推进家庭医生签约服务指导意见的通知[Z].2016.
[3]LI X,KRUMHOLZ H M,YIP W,et al.Quality of primary health care in China:challenges and recommendations[J].The Lancet,2020,395(10239):1802-1812.DOI:10.1016/S0140-6736(20)30122-7.
[4]李心怡,朱珠,练璐,等.家庭医生服务供给及保障机制的国际经验对我国的启示[J].卫生软科学,2020,34(7):92-97.DOI:10.3969/j.issn.1003-2800.2020.07.020.
LI X Y,ZHU Z,LIAN L,et al.International experience and enlightenment of service supply and guarantee mechanism of family doctor[J].Soft Science of Health,2020,34(7):92-97.DOI:10.3969/j.issn.1003-2800.2020.07.020.
[5]张莉,廖华,刘紫燕.阿托伐他汀联合rhBNP治疗AMI合并心力衰竭的临床疗效[J].检验医学与临床,2017,14(19):2836-2838.DOI:10.3969/j.issn.1672-9455.2017.19.008.
ZHANG L,LIAO H,LIU Z Y.Clinical efficacy of atorvastatin combined with rhBNP in treating acute myocardial infarction complicating heart failure[J].Laboratory Medicine and Clinic,2017,14(19):2836-2838.DOI:10.3969/j.issn.1672-9455.2017.19.008.
[6]TRISOLINI M,AGGARWAL J,LEUNG M,et al.The Medicare Physician Group Practice Demonstration:lessons learned on improving quality and efficiency in health care[EB/OL].(2008-01-15)[2020-08-01].http://www.mendeley.com/research/medicare-physician-group-practice-demonstration-lessons-learned-improving-quality-efficiency-health/.
[7]GRYTTEN J,S?RENSEN R.Type of contract and supplier-induced demand for primary physicians in Norway[J].Journal of Health Economics,2001,20(3):379-393.DOI:10.1016/s0167-6296(00)00087-4.
[8]SEKIMOTO M,II M.Supplier-induced demand for chronic disease care in Japan:multilevel analysis of the association between physician density and physician-patient encounter frequency[J].Value in Health Regional Issues,2015(6):103-110.DOI:10.1016/j.vhri.2015.03.010.
[9]张译方.中美医生诱导需求差异研究[J].企业导报,2013,14(14):180-181.DOI:CNKI:SUN:QYDB.0.2013-14-125.
[10]NEWHOUSE J P.A model of physician pricing[J].South Econ J,1970,37(2):174.DOI:10.2307/1056127.
[11]谷茜,陈英耀.国外卫生系统绩效支付实践对我国的借鉴[J].中国医院管理,2012,32(1):27-29.
[12]BORGHI J,MAYUMANA I,MASHASI I,et al.Protocol for the evaluation of a pay for performance programme in Pwani region in Tanzania:a controlled before and after study[J].Implement Sci,2013,8:80.DOI:10.1186/1748-5908-8-80.
[13]SAINT-LARY O,BERNARD E,SICSIC J,et al.Why did most French GPs choose not to join the voluntary national pay-for-performance program[J].PLoS One,2013,8(9):e72684.DOI:10.1371/journal.pone.0072684.
[14]STRIK M.Public health,private concern.The organizational development of public health in the Netherlands at the beginning of the twentieth century[J].Eur J Public Heal,1996,6(2):81-86.DOI:10.1093/eurpub/6.2.81.
[15]王毓丰,陈永法.商业保险衔接基本医疗保险的国际经验及启示[J].卫生经济研究,2019,36(9):60-64.DOI:10.14055/j.cnki.33-1056/f.2019.09.018.
WANG Y F,CHEN Y F.International experience and enlightenment of linking basic insurance to commercial insurance[J].Health Economics Research,2019,36(9):60-64.DOI:10.14055/j.cnki.33-1056/f.2019.09.018.
[16]肖琦琪.基于经济学角度的医生诱导需求研究[J].科技经济导刊,2020,28(13):236.
[17]王凡,温小霓.医疗供方诱导需求理论及其在我国的实证研究[J].中国卫生经济,2007,26(3):7-10.DOI:10.3969/j.issn.1003-0743.2007.03.002.
WANG F,WEN X N.An empirical study of physician-induced demand in China[J].Chinese Health Economics,2007,26(3):7-10.DOI:10.3969/j.issn.1003-0743.2007.03.002.
[18]刘巧,李丽清.我国卫生总费用发展趋势与未来展望[J].中国全科医学,2017,20(7):859-864.DOI:10.3969/j.issn.1007-9572.2017.07.019.
LIU Q,LI L Q.Development trend and future prospects of total expenditure on health in China[J].Chinese General Practice,2017,20(7):859-864.DOI:10.3969/j.issn.1007-9572.2017.07.019.
[19]贾洪波,王清河.医疗保障按绩效付费方式的绩效标准研究:来自多国的实践[J].中国卫生经济,2015,34(10):13-15.DOI:10.7664/CHE20151003.
JIA H B,WANG Q H.The study on the criteria of performances of pay-for-performance in medical insurance:in term of the practices from several countries[J].Chinese Health Economics,2015,34(10):13-15.DOI:10.7664/CHE20151003.
[20]MOHAMADLOO A,ZAREIN-DOLAB S,RAMEZANKHANI A,et al.The main factors of induced demand for medicine prescription:a qualitative study[J].Iran J Pharm Res,2019,18(1):479-487.
[21]VAN DE VOORDE C,VAN DOORSLAER E,SCHOKKAERT E.Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demand[J].Health Econ,2001,10(5):457-471.DOI:10.1002/hec.631.
[22]SUGAWARA S,NAKAMURA J.Gatekeeper incentives and demand inducement: an empirical analysis of care managers in the Japanese long-term care insurance program[J].Journal of The Japanese and International Economies,2016,40:1-16.DOI:10.1016/j.jjie.2016.03.001.
[23]MCDONALD R,WHITE J,MARMOR T R.Paying for performance in primary medical care:learning about and learning from "success" and "failure" in England and California[J].J Health Polit Policy Law,2009,34(5):747-776.DOI:10.1215/03616878-2009-024.